FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2517996987> ?p ?o ?g. }

• W2517996987 abstract "ABSTRACT The type I signal peptidase of Staphylococcus aureus , SpsB, is an attractive antibacterial target because it is essential for viability and extracellularly accessible. We synthesized compound 103, a novel arylomycin-derived inhibitor of SpsB with significant potency against various clinical S. aureus strains (MIC of ~1 µg/ml). The predominant clinical strain USA300 developed spontaneous resistance to compound 103 with high frequency, resulting from single point mutations inside or immediately upstream of cro / cI , a homolog of the lambda phage transcriptional repressor cro . These cro / cI mutations led to marked (>50-fold) overexpression of three genes encoding a putative ABC transporter. Overexpression of this ABC transporter was both necessary and sufficient for resistance and, notably, circumvented the essentiality of SpsB during in vitro culture. Mutation of its predicted ATPase gene abolished resistance, suggesting a possible role for active transport; in these bacteria, resistance to compound 103 occurred with low frequency and through mutations in spsB . Bacteria overexpressing the ABC transporter and lacking SpsB were capable of secreting a subset of proteins that are normally cleaved by SpsB and instead were cleaved at a site distinct from the canonical signal peptide. These bacteria secreted reduced levels of virulence-associated proteins and were unable to establish infection in mice. This study reveals the mechanism of resistance to a novel arylomycin derivative and demonstrates that the nominal essentiality of the S. aureus signal peptidase can be circumvented by the upregulation of a putative ABC transporter in vitro but not in vivo . IMPORTANCE The type I signal peptidase of Staphylococcus aureus (SpsB) enables the secretion of numerous proteins by cleavage of the signal peptide. We synthesized an SpsB inhibitor with potent activity against various clinical S. aureus strains. The predominant S. aureus strain USA300 develops resistance to this inhibitor by mutations in a novel transcriptional repressor ( cro / cI ), causing overexpression of a putative ABC transporter. This mechanism promotes the cleavage and secretion of various proteins independently of SpsB and compensates for the requirement of SpsB for viability in vitro . However, bacteria overexpressing the ABC transporter and lacking SpsB secrete reduced levels of virulence-associated proteins and are unable to infect mice. This study describes a bacterial resistance mechanism that provides novel insights into the biology of bacterial secretion." @default.
• W2517996987 created "2016-09-16" @default.
• W2517996987 creator A5000754889 @default.
• W2517996987 creator A5000779800 @default.
• W2517996987 creator A5020560071 @default.
• W2517996987 creator A5026032600 @default.
• W2517996987 creator A5033486314 @default.
• W2517996987 creator A5034080122 @default.
• W2517996987 creator A5036928408 @default.
• W2517996987 creator A5039084014 @default.
• W2517996987 creator A5039127243 @default.
• W2517996987 creator A5044914775 @default.
• W2517996987 creator A5045035280 @default.
• W2517996987 creator A5055533449 @default.
• W2517996987 creator A5062372256 @default.
• W2517996987 creator A5074916693 @default.
• W2517996987 creator A5078585814 @default.
• W2517996987 creator A5079564933 @default.
• W2517996987 creator A5080192285 @default.
• W2517996987 creator A5082175561 @default.
• W2517996987 creator A5083894198 @default.
• W2517996987 date "2016-11-02" @default.
• W2517996987 modified "2023-10-13" @default.
• W2517996987 title "A Putative Bacterial ABC Transporter Circumvents the Essentiality of Signal Peptidase" @default.
• W2517996987 cites W1571482242 @default.
• W2517996987 cites W1667874699 @default.
• W2517996987 cites W1971469730 @default.
• W2517996987 cites W1995808283 @default.
• W2517996987 cites W1997617722 @default.
• W2517996987 cites W2002545871 @default.
• W2517996987 cites W2021642076 @default.
• W2517996987 cites W2025841140 @default.
• W2517996987 cites W2044087791 @default.
• W2517996987 cites W2059265460 @default.
• W2517996987 cites W2068398119 @default.
• W2517996987 cites W2085719025 @default.
• W2517996987 cites W2088639496 @default.
• W2517996987 cites W2094124133 @default.
• W2517996987 cites W2097294790 @default.
• W2517996987 cites W2100749074 @default.
• W2517996987 cites W2110763275 @default.
• W2517996987 cites W2119261344 @default.
• W2517996987 cites W2130759889 @default.
• W2517996987 cites W2132145187 @default.
• W2517996987 cites W2146290818 @default.
• W2517996987 cites W2147925680 @default.
• W2517996987 cites W2152783224 @default.
• W2517996987 cites W2168167613 @default.
• W2517996987 cites W2172734967 @default.
• W2517996987 cites W2218183054 @default.
• W2517996987 cites W2404934570 @default.
• W2517996987 cites W2949982582 @default.
• W2517996987 doi "https://doi.org/10.1128/mbio.00412-16" @default.
• W2517996987 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5013292" @default.
• W2517996987 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27601569" @default.
• W2517996987 hasPublicationYear "2016" @default.
• W2517996987 type Work @default.
• W2517996987 sameAs 2517996987 @default.
• W2517996987 citedByCount "14" @default.
• W2517996987 countsByYear W25179969872017 @default.
• W2517996987 countsByYear W25179969872018 @default.
• W2517996987 countsByYear W25179969872019 @default.
• W2517996987 countsByYear W25179969872020 @default.
• W2517996987 countsByYear W25179969872021 @default.
• W2517996987 countsByYear W25179969872022 @default.
• W2517996987 countsByYear W25179969872023 @default.
• W2517996987 crossrefType "journal-article" @default.
• W2517996987 hasAuthorship W2517996987A5000754889 @default.
• W2517996987 hasAuthorship W2517996987A5000779800 @default.
• W2517996987 hasAuthorship W2517996987A5020560071 @default.
• W2517996987 hasAuthorship W2517996987A5026032600 @default.
• W2517996987 hasAuthorship W2517996987A5033486314 @default.
• W2517996987 hasAuthorship W2517996987A5034080122 @default.
• W2517996987 hasAuthorship W2517996987A5036928408 @default.
• W2517996987 hasAuthorship W2517996987A5039084014 @default.
• W2517996987 hasAuthorship W2517996987A5039127243 @default.
• W2517996987 hasAuthorship W2517996987A5044914775 @default.
• W2517996987 hasAuthorship W2517996987A5045035280 @default.
• W2517996987 hasAuthorship W2517996987A5055533449 @default.
• W2517996987 hasAuthorship W2517996987A5062372256 @default.
• W2517996987 hasAuthorship W2517996987A5074916693 @default.
• W2517996987 hasAuthorship W2517996987A5078585814 @default.
• W2517996987 hasAuthorship W2517996987A5079564933 @default.
• W2517996987 hasAuthorship W2517996987A5080192285 @default.
• W2517996987 hasAuthorship W2517996987A5082175561 @default.
• W2517996987 hasAuthorship W2517996987A5083894198 @default.
• W2517996987 hasBestOaLocation W25179969871 @default.
• W2517996987 hasConcept C104317684 @default.
• W2517996987 hasConcept C10858879 @default.
• W2517996987 hasConcept C143065580 @default.
• W2517996987 hasConcept C149011108 @default.
• W2517996987 hasConcept C150194340 @default.
• W2517996987 hasConcept C153911025 @default.
• W2517996987 hasConcept C158448853 @default.
• W2517996987 hasConcept C167625842 @default.
• W2517996987 hasConcept C176944494 @default.
• W2517996987 hasConcept C44312359 @default.
• W2517996987 hasConcept C501734568 @default.
• W2517996987 hasConcept C523546767 @default.
• W2517996987 hasConcept C54355233 @default.

• next